aTyr Pharma Inc (LIFE)
3.08
-0.19 -5.81%
NASDAQ
Oct 30, 16:58
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 8.582M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.45 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -16.31M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -3.41K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 30.82M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 2.152 |
| PE Ratio | -- |
| Price to Book Value | 0.8538 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.1378 |
| Free Cash Flow (Quarterly) | -6.422M |
| Return on Equity | Upgrade |
View All LIFE News
News
-
WireHeadlineTime (ET)
-
Globe Newswire10/29 07:00
-
Globe Newswire10/27 07:00
-
MT Newswires10/26 09:12
-
MT Newswires10/26 08:06
-
SA Breaking News10/26 07:50
-
Globe Newswire10/26 07:00
-
SA Breaking News10/08 19:22
-
Globe Newswire10/07 08:00
-
Globe Newswire09/21 08:35
-
MT Newswires09/15 13:14
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/16/2020 17:00 EST | Misc | aTyr Pharma Inc Third Quarter Earnings Conference Call for 2020 |
| 11/16/2020 | Earnings | aTyr Pharma Inc Third Quarter Earnings Results for 2020 |
| 08/13/2020 17:00 EDT | Misc | aTyr Pharma Inc Second Quarter Earnings Conference Call for 2020 |
| 08/13/2020 | Earnings | aTyr Pharma Inc Second Quarter Earnings Result for 2020 |
| 05/12/2020 17:00 EDT | Misc | aTyr Pharma Inc First Quarter Earnings Conference Call for 2020 |
| 05/12/2020 | Earnings | aTyr Pharma Inc First Quarter Earnings Result for 2020 |
| 05/06/2020 08:30 PDT | Misc | aTyr Pharma Inc Annual General Meeting for 2019 |
| 03/26/2020 | Misc | aTyr Pharma Inc Annual Report for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.atyrpharma.com
- Investor Relations URL: http://atyrpharma.investorroom.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Nov. 16, 2020
- Last Earnings Release: Aug. 13, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It's lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.08 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- LIFE Tweets Stocktwits
Advertisement
